In 2023, the average length of stay for patients with malignant neoplasm of the bladder in the UK was 3.5 days. The forecast indicates a steady decline from 3.4 days in 2024 to 3 days by 2028. This reflects a year-on-year decrease of approximately 2.94%. The compound annual growth rate (CAGR) over these five years is approximately -2.99%, signaling consistent improvements in hospital efficiency and patient management.
Future trends to monitor include advances in treatment options, early diagnosis techniques, and potential changes in healthcare policies, all of which could further reduce hospital stays. Additionally, the integration of telemedicine and outpatient care can significantly influence hospital strategies and patient recovery times.
